LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1509 | 3124 | 0.4831 | 0.3154 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 765 | 676 | 3124 | 0.2164 | -0.0377 |
Hs 578T | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 765 | 2930 | 3124 | 0.9380 | 0.9178 |
Hs 578T | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 765 | 388 | 3124 | 0.1242 | -0.1598 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 765 | 915 | 3124 | 0.2931 | 0.0638 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 2750 | 3124 | 0.8801 | 0.8413 |
Hs 578T | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 765 | 618 | 3124 | 0.1978 | -0.0623 |
Hs 578T | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 765 | 376 | 3124 | 0.1203 | -0.1649 |
Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 765 | 292 | 3124 | 0.0935 | -0.2005 |
Hs 578T | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 765 | 2756 | 3124 | 0.8823 | 0.8441 |
Hs 578T | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 765 | 3008 | 3124 | 0.9628 | 0.9508 |
Hs 578T | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 765 | 3075 | 3124 | 0.9844 | 0.9793 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1616 | 3124 | 0.5174 | 0.3609 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1850 | 3124 | 0.5921 | 0.4598 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 482 | 3124 | 0.1543 | -0.1200 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 416 | 3124 | 0.1334 | -0.1477 |
Hs 578T | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1140 | 3124 | 0.3649 | 0.1589 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 765 | 3135 | 3124 | 1.0033 | 1.0044 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 2852 | 3124 | 0.9128 | 0.8845 |
Hs 578T | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 796 | 3124 | 0.2549 | 0.0133 |
Hs 578T | R406 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1840 | 3124 | 0.5890 | 0.4557 |
Hs 578T | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1368 | 3124 | 0.4378 | 0.2555 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 3049 | 3124 | 0.9759 | 0.9681 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 765 | 603 | 3124 | 0.1930 | -0.0687 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 765 | 578 | 3124 | 0.1850 | -0.0793 |